Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Laar, J.M. van"'
Autor:
Broens, B., Laken, C.J. van der, Zwezerijnen, G.J.C., Nossent, E.J., Meijboom, L.J., Spierings, J., Vries-Bouwstra, J.K. de, Laar, J.M. van, Voskuyl, A.E.
Publikováno v:
Frontiers in Immunology, 13:923869
Broens, B, van der Laken, C J, Zwezerijnen, G J C, Nossent, E J, Meijboom, L J, Spierings, J, de Vries-Bouwstra, J K, van Laar, J M & Voskuyl, A E 2022, ' Positron Emission Tomography to Improve Assessment of Interstitial Lung Disease in Patients With Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation ', Frontiers in Immunology, vol. 13, 923869 . https://doi.org/10.3389/fimmu.2022.923869, https://doi.org/10.3389/fimmu.2022.923869
Frontiers in Immunology, 13. FRONTIERS MEDIA SA
Frontiers in Immunology, 13
Broens, B, van der Laken, C J, Zwezerijnen, G J C, Nossent, E J, Meijboom, L J, Spierings, J, de Vries-Bouwstra, J K, van Laar, J M & Voskuyl, A E 2022, ' Positron Emission Tomography to Improve Assessment of Interstitial Lung Disease in Patients With Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation ', Frontiers in Immunology, vol. 13, 923869 . https://doi.org/10.3389/fimmu.2022.923869, https://doi.org/10.3389/fimmu.2022.923869
Frontiers in Immunology, 13. FRONTIERS MEDIA SA
Frontiers in Immunology, 13
Positron emission tomography (PET) is a promising technique to improve the assessment of systemic sclerosis associated interstitial lung disease (SSc-ILD). This technique could be of particular value in patients with severe diffuse cutaneous SSc (dcS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be2e69493d18df88c7a2fb2b6e0eeac8
https://doi.org/10.3389/fimmu.2022.923869
https://doi.org/10.3389/fimmu.2022.923869
Autor:
Dirikgil, E., Tas, S.W., Verburgh, C.A., Soonawala, D., Hak, A.E., Remmelts, H.H.F., IJpelaar, D., Laverman, G.D., Rutgers, A., Laar, J.M. van, Moens, H.J.B., Verhoeven, P.M.J., Rabelink, T.J., Bos, W.J.W., Teng, Y.K.O., Autoimmune Research Collaboration Hub (ARCH) study group
Publikováno v:
Rheumatology advances in practice, 6(2):rkac045. Oxford Univ. Press, New York
Rheumatology Advances in Practice, 6(2). OXFORD UNIV PRESS
Rheumatology Advances in Practice, 6(2):rkac045. Oxford University Press
Rheumatology Advances in Practice, 6(2). OXFORD UNIV PRESS
Rheumatology Advances in Practice, 6(2):rkac045. Oxford University Press
Objectives Diagnosing patients with ANCA-associated vasculitis (AAV) can be challenging owing to its rarity and complexity. Diagnostic delay can have severe consequences, such as chronic organ damage or even death. Given that few studies have address
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8252ba4a92215aaf47fcc3105192e7db
https://hdl.handle.net/1887/3563232
https://hdl.handle.net/1887/3563232
Autor:
Abouyahya, I., Liem, S.I.E., Amoura, Z., Fonseca, J.E., Chaigne, B., Cutolo, M., Doria, A., Fischer-Betz, R., Guimaraes, V., Huizinga, T.W.J., Laar, J.M. van, Martin, T., Matucci-Cerinic, M., Montecucco, C., Schneider, M., Smith, V., Muller-Ladner, U., Vries-Bouwstra, J.K. de
Objective. Health-Related Quality of Life (HRQoL) in adult patients with mixed connective tissue disease (MCTD) has not been described so far. Therefore, we performed an explorative study to evaluate HRQoL in MCTD patients.Methods. MCTD patients fulf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______202::8e56340aae45b5b1dc3712d6bc78da00
https://hdl.handle.net/1887/3458814
https://hdl.handle.net/1887/3458814
Autor:
Spierings, J., Ende, C.H.M. van den, Schriemer, R.M., Moens, H.J.B., Bijl, E.A. van der, Bonte-Mineur, F., Buck, M.P.D. de, Kanter, M.A.E. de, Knaapen-Hans, H.K.A., Laar, J.M. van, Mulder, U.D.J., Potjewijd, J., Pundert, L.A.J. de, Schoonbrood, T.H.M., Schouffoer, A.A., Stel, A.J., Vercoutere, W., Voskuyl, A.E., Vries-Bouwstra, J.K. de, Vonk, M.C., ARCH Study Grp
Publikováno v:
Rheumatology, 59(6), 1226-1232. OXFORD UNIV PRESS
Rheumatology (Oxford, England), 59(6), 1226-1232. Oxford University Press
Rheumatology, 59(6), 1226-1232. Oxford University Press
Spierings, J, van den Ende, C H M, Schriemer, R M, Bernelot Moens, H J, van der Bijl, E A, Bonte-Mineur, F, de Buck, M P D, de Kanter, M A E, Knaapen-Hans, H K A, van Laar, J M, Mulder, U D J, Potjewijd, J, de Pundert, L A J, Schoonbrood, T H M, Schouffoer, A A, Stel, A J, Vercoutere, W, Voskuyl, A E, de Vries-Bouwstra, J K, Vonk, M C & ARCH Study Group 2020, ' How do patients with systemic sclerosis experience currently provided healthcare and how should we measure its quality? ', Rheumatology (Oxford, England), vol. 59, no. 6, pp. 1226-1232 . https://doi.org/10.1093/rheumatology/kez417
Rheumatology, 59, 6, pp. 1226-1232
Rheumatology (Oxford, England)
Rheumatology, 59, 1226-1232
Rheumatology, 59(6):kez417, 1226-1232. Oxford University Press
Rheumatology (Oxford, England), 59(6), 1226-1232. Oxford University Press
Rheumatology, 59(6), 1226-1232. Oxford University Press
Spierings, J, van den Ende, C H M, Schriemer, R M, Bernelot Moens, H J, van der Bijl, E A, Bonte-Mineur, F, de Buck, M P D, de Kanter, M A E, Knaapen-Hans, H K A, van Laar, J M, Mulder, U D J, Potjewijd, J, de Pundert, L A J, Schoonbrood, T H M, Schouffoer, A A, Stel, A J, Vercoutere, W, Voskuyl, A E, de Vries-Bouwstra, J K, Vonk, M C & ARCH Study Group 2020, ' How do patients with systemic sclerosis experience currently provided healthcare and how should we measure its quality? ', Rheumatology (Oxford, England), vol. 59, no. 6, pp. 1226-1232 . https://doi.org/10.1093/rheumatology/kez417
Rheumatology, 59, 6, pp. 1226-1232
Rheumatology (Oxford, England)
Rheumatology, 59, 1226-1232
Rheumatology, 59(6):kez417, 1226-1232. Oxford University Press
Objectives To gain insight into SSc patients’ perspective on quality of care and to survey their preferred quality indicators. Methods An online questionnaire about healthcare setting, perceived quality of care (CQ index) and quality indicators, wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8e9965fd83f086a4f551177f3277d26
https://academic.oup.com/rheumatology/article/59/6/1226/5572267
https://academic.oup.com/rheumatology/article/59/6/1226/5572267
Autor:
Dirikgil, E., Tas, S.W., Rutgers, A., Verhoeven, P.M.J., Laar, J.M. van, Hagen, E.C., Tekstra, J., Hak, A.E.L., Paassen, P. van, Kok, M.R., Goldschmeding, R., Dam, B. van, Douma, C.E., Remmelts, H.H.F., Sanders, J.F., Jonker, J.T., Rabelink, T.J., Damoiseaux, J.G.M.C., Moens, H.J.B., Bos, W.J.W., Teng, Y.K.O., Arthrit Res Collaboration Hub Cons
Publikováno v:
Netherlands Journal of Medicine, 78(2), 71-82. VAN ZUIDEN COMMUNICATIONS
Introduction: Despite the availability of several guidelines on the diagnosis and treatment of antineutrophil cytoplasmic antibody-associated vasculitis (AAV), clinical routine practice will only improve when an implementation strategy is in place to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d86caf9fec41f9af1f164ecb971d2075
https://hdl.handle.net/1887/3181302
https://hdl.handle.net/1887/3181302
Autor:
Roodenrijs, N.M.T., Hair, M.J.H. de, Goes, M.C. van der, Jacobs, J.W.G., Welsing, P.M.J., Heijde, D. van der, Aletaha, D., Dougados, M., Hyrich, K.L., McInnes, I.B., Mueller-Ladner, U., Senolt, L., Szekanecz, Z., Laar, J.M. van, Nagy, G., EULAR Recommendations
Publikováno v:
Annals of the Rheumatic Diseases, 77(12), 1705-1709
ObjectivesPatients with difficult-to-treat rheumatoid arthritis (RA) remain symptomatic despite treatment according to current European League Against Rheumatism (EULAR) management recommendations. These focus on early phases of the disease and pharm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f451045a946ba64e15f6f791a9fda68d
Autor:
Diaz-Gallo, L.M., Simeon, C.P., Broen, J.C.A., Ortego-Centeno, N., Beretta, L., Vonk, M.C., Carreira, P.E., Vargas, S., Roman-Ivorra, J.A., Gonzalez-Gay, M.A., Tolosa, C., Lopez-Longo, F.J., Espinosa, G., Vicente, E.F., Hesselstrand, R., Riemekasten, G., Witte, T. de, Distler, J.H., Voskuyl, A.E., Schuerwegh, A.J., Shiels, P.G., Nordin, A., Padyukov, L., Hoffmann-Vold, A.M., Scorza, R., Lunardi, C., Airo, P., Laar, J.M. van, Hunzelmann, N., Gathof, B.S., Kreuter, A., Herrick, A., Worthington, J., Denton, C.P., Zhou, X., Arnett, F.C., Fonseca, C., Koeleman, B.P., Assasi, S., Radstake, T.R.D.J., Mayes, M.D., Martin, J.
Publikováno v:
Annals of the Rheumatic Diseases, 72, 7, pp. 1233-8
Recercat. Dipósit de la Recerca de Catalunya
instname
Diaz-Gallo, L M, Simeon, C P, Broen, J C, Ortego-Centeno, N, Beretta, L, Vonk, M C, Carreira, P E, Vargas, S, Roman-Ivorra, J A, Gonzalez-Gay, M A, Tolosa, C, Lopez-Longo, F J, Espinosa, G, Vicente, E F, Hesselstrand, R, Riemekasten, G, Witte, T, Distler, J H W, Voskuyl, A E, Schuerwegh, A J, Shiels, P G, Nordin, A, Padyukov, L, Hoffmann-Vold, A M, Scorza, R, Lunardi, C, Airo, P, van Laar, J M, Hunzelmann, N, Gathof, B S, Kreuter, A, Herrick, A, Worthington, J, Denton, C P, Zhou, X D, Arnett, F C, Fonseca, C, Koeleman, B P C, Assasi, S, Radstake, T R D J, Mayes, M D & Martin, J 2013, ' Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility ', Annals of the Rheumatic Diseases, vol. 72, no. 7, pp. 1233-1238 . https://doi.org/10.1136/annrheumdis-2012-202357
Dipòsit Digital de la UB
Universidad de Barcelona
Annals of the Rheumatic Diseases, 72(7), 1233-1238. BMJ Publishing Group
Annals of the Rheumatic Diseases, 72, 1233-8
Recercat. Dipósit de la Recerca de Catalunya
instname
Diaz-Gallo, L M, Simeon, C P, Broen, J C, Ortego-Centeno, N, Beretta, L, Vonk, M C, Carreira, P E, Vargas, S, Roman-Ivorra, J A, Gonzalez-Gay, M A, Tolosa, C, Lopez-Longo, F J, Espinosa, G, Vicente, E F, Hesselstrand, R, Riemekasten, G, Witte, T, Distler, J H W, Voskuyl, A E, Schuerwegh, A J, Shiels, P G, Nordin, A, Padyukov, L, Hoffmann-Vold, A M, Scorza, R, Lunardi, C, Airo, P, van Laar, J M, Hunzelmann, N, Gathof, B S, Kreuter, A, Herrick, A, Worthington, J, Denton, C P, Zhou, X D, Arnett, F C, Fonseca, C, Koeleman, B P C, Assasi, S, Radstake, T R D J, Mayes, M D & Martin, J 2013, ' Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility ', Annals of the Rheumatic Diseases, vol. 72, no. 7, pp. 1233-1238 . https://doi.org/10.1136/annrheumdis-2012-202357
Dipòsit Digital de la UB
Universidad de Barcelona
Annals of the Rheumatic Diseases, 72(7), 1233-1238. BMJ Publishing Group
Annals of the Rheumatic Diseases, 72, 1233-8
ObjectiveThe interleukin 2 (IL-2) and interleukin 21 (IL-21) locus at chromosome 4q27 has been associated with several autoimmune diseases, and both genes are related to immune system functions. The aim of this study was to evaluate the role of the I
Autor:
Rhijn-Brouwer, F.C. van, Vonk, M.C., Velden, W.J.F.M. van der, Voskuyl, A.E., Loosdrecht, A.A. van de, Vries-Bouwstra, J.K. de, Marijt, W.A., Rhenen, A. van, Kuball, J., Laar, J.M. van
Publikováno v:
Nederlands Tijdschrift voor Reumatologie, 3, pp. 16-22
Nederlands Tijdschrift voor Reumatologie, 3, 16-22
Nederlands Tijdschrift voor Reumatologie, 3, 16-22
Item does not contain fulltext
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e8415dc58559f7805da3f192af805a1c
https://hdl.handle.net/2066/172204
https://hdl.handle.net/2066/172204
Autor:
Cuppen, B.V.J., Fu, J., Wietmarschen, H.A. van, Harms, A.C., Koval, S., Marijnissen, A.C.A., Peeters, J.J.W., Bijlsma, J.W.J., Tekstra, J., Laar, J.M. van, Hankemeier, T., Lafeber, F.P.J.G., Greef, J. van der
Publikováno v:
PLoS ONE, 9, 11
In clinical practice, approximately one-Third of patients with rheumatoid arthritis(RA) respond insufficiently to TNF-α inhibitors (TNFis). The aim of the study was to explore the use of a metabolomics to identify predictors for the outcome of TNFi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9ecb74df0aefd87009f92704a210cf34
http://resolver.tudelft.nl/uuid:fd9d4a0c-52d3-4c16-a838-58b26ec94f73
http://resolver.tudelft.nl/uuid:fd9d4a0c-52d3-4c16-a838-58b26ec94f73
Autor:
Laar, J.M. van, Farge, D., Sont, J.K., Naraghi, K., Marjanovic, Z., Larghero, J., Schuerwegh, A.J., Marijt, E.W.A., Vonk, M.C., Schattenberg, A.V., Matucci-Cerinic, M., Voskuyl, A.E., Loosdrecht, A.A. van de, Daikeler, T., Kotter, I., Schmalzing, M., Martin, T., Lioure, B., Weiner, S.M., Kreuter, A., Deligny, C., Durand, J.M., Emery, P., Machold, K.R., Sarrot-Reynauld, F., Warnatz, K., Adoue, D.F.P., Constans, J., Tony, H.P., Papa, N. del, Fassas, A., Himsel, A., Launay, D., Monaco, A. lo, Philippe, P., Quere, I., Rich, E., Westhovens, R., Griffiths, B., Saccardi, R., Hoogen, F.H. van den, Fibbe, W.E., Socie, G., Gratwohl, A., Tyndall, A., EBMT EULAR Scleroderma Study Grp
Publikováno v:
van Laar, J M, Farge, D, Sont, J K, Naraghi, K, Marjanovic, Z, Larghero, J, Schuerwegh, A J, Marijt, E W A, Vonk, M C, Schattenberg, A V, Matucci-Cerinic, M, Voskuyl, A E, van de Loosdrecht, A A, Daikeler, T, Kotter, I, Schmalzing, M, Martin, T, Lioure, B, Weiner, S M, Kreuter, A, Deligny, C, Durand, J M, Emery, P, Machold, K R, Sarrot-Reynauld, F, Warnatz, K, Adoue, D F P, Constans, J, Tony, H P, Del Papa, N, Fassas, A, Himsel, A, Launay, D, Lo Monaco, A, Philippe, P, Quere, I, Rich, E, Westhovens, R, Griffiths, B, Saccardi, R, van den Hoogen, F H, Fibbe, W E, Socie, G, Gratwohl, A & Tyndall, A 2014, ' Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis A Randomized Clinical Trial ', JAMA, vol. 311, no. 24, pp. 2490-2498 . https://doi.org/10.1001/jama.2014.6368
Journal of the American Medical Association, 311(24), 2490-2498
Jama : Journal of the American Medical Association, 311, 2490-8
Jama : Journal of the American Medical Association, 311, 24, pp. 2490-8
JAMA, 311(24), 2490-2498. American Medical Association
Journal of the American Medical Association, 311(24), 2490-2498
Jama : Journal of the American Medical Association, 311, 2490-8
Jama : Journal of the American Medical Association, 311, 24, pp. 2490-8
JAMA, 311(24), 2490-2498. American Medical Association
Contains fulltext : 136804.pdf (Publisher’s version ) (Open Access) IMPORTANCE: High-dose immunosuppressive therapy and autologous hematopoietic stem cell transplantation (HSCT) have shown efficacy in systemic sclerosis in phase 1 and small phase 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::391617a24aaba7a2a180612542c8128f
https://hdl.handle.net/1887/103060
https://hdl.handle.net/1887/103060